- Home
- ALM vs NRIX Comparison
ALM vs NRIX Comparison
Compare ALM & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALM
- NRIX
- Stock Information
- Founded
- ALM N/A
- NRIX 2009
- Country
- ALM Canada
- NRIX United States
- Employees
- ALM N/A
- NRIX N/A
- Industry
- ALM Other Metals and Minerals
- NRIX Biotechnology: Pharmaceutical Preparations
- Sector
- ALM Basic Materials
- NRIX Health Care
- Exchange
- ALM Nasdaq
- NRIX Nasdaq
- Market Cap
- ALM 958.4M
- NRIX 970.1M
- IPO Year
- ALM N/A
- NRIX 2020
- Fundamental
- Price
- ALM $3.76
- NRIX $11.04
- Analyst Decision
- ALM
- NRIX Strong Buy
- Analyst Count
- ALM 0
- NRIX 15
- Target Price
- ALM N/A
- NRIX $29.13
- AVG Volume (30 Days)
- ALM 1.5M
- NRIX 1.0M
- Earning Date
- ALM 08-14-2025
- NRIX 07-09-2025
- Dividend Yield
- ALM N/A
- NRIX N/A
- EPS Growth
- ALM N/A
- NRIX N/A
- EPS
- ALM N/A
- NRIX N/A
- Revenue
- ALM $20,120,360.00
- NRIX $88,381,000.00
- Revenue This Year
- ALM $175.95
- NRIX $71.51
- Revenue Next Year
- ALM $85.57
- NRIX N/A
- P/E Ratio
- ALM N/A
- NRIX N/A
- Revenue Growth
- ALM 24.46
- NRIX 41.86
- 52 Week Low
- ALM $3.16
- NRIX $8.18
- 52 Week High
- ALM $5.50
- NRIX $29.56
- Technical
- Relative Strength Index (RSI)
- ALM N/A
- NRIX 40.64
- Support Level
- ALM N/A
- NRIX $11.13
- Resistance Level
- ALM N/A
- NRIX $12.33
- Average True Range (ATR)
- ALM 0.00
- NRIX 0.56
- MACD
- ALM 0.00
- NRIX -0.09
- Stochastic Oscillator
- ALM 0.00
- NRIX 9.89
About ALM Almonty Industries Inc. Common Shares
Almonty Industries Inc is engaged in the mining, processing, and shipping of tungsten concentrate from its Los Santos tungsten mine located near Salamanca, Spain - the Los Santos Mine, the processing and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal - the Panasqueira Mine, the evaluation of its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora - the Valtreixal Mine, as well as the exploration and evaluation of its Sangdong tungsten mine project located in Gangwon Province, Republic of Korea - the Sangdong Mine.
About NRIX Nurix Therapeutics Inc. Common stock
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.